FORA Capital’s Zimmer Biomet ZBH Stock Holding History

FORA Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.52M	Buy	16,774 +13,299	+383%	+$1.22M	0.11%	184
2025 Q4	$312K	Sell	3,475 -3,501	-50%	-$332K	0.04%	358
2025 Q3	$687K	Sell	6,976 -18,319	-72%	-$1.82M	0.12%	216
2025 Q2	$2.31M	Buy	+25,295	New	+$2.45M	0.26%	102
2025 Q1	–	Sell	-15,828	Closed	-$1.67M	–	663
2024 Q4	$1.67M	Sell	15,828 -22,486	-59%	-$2.41M	0.19%	159
2024 Q3	$4.14M	Buy	38,314 +2,371	+7%	+$259K	0.49%	61
2024 Q2	$3.9M	Buy	+35,943	New	+$4.24M	0.48%	67
2023 Q4	–	Sell	-11,700	Closed	-$1.31M	–	669
2023 Q3	$1.31M	Buy	+11,700	New	+$1.49M	0.12%	207
2022 Q3	–	Sell	-3,505	Closed	-$368K	–	608
2022 Q2	$368K	Buy	+3,505	New	+$416K	0.07%	300
2022 Q1	–	Sell	-3,119	Closed	-$385K	–	651
2021 Q4	$385K	Buy	+3,119	New	+$408K	0.15%	184
2021 Q1	–	Sell	-3,944	Closed	-$590K	–	1157
2020 Q4	$590K	Buy	3,944 +2,680	+212%	+$379K	0.09%	251
2020 Q3	$167K	Buy	+1,264	New	+$165K	0.11%	204
2020 Q1	–	Sell	-13,018	Closed	-$1.89M	–	1394
2019 Q4	$1.89M	Buy	+13,018	New	+$1.8M	0.19%	142

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FORA Capital's ZBH Position: Q1 2026 in Review

FORA Capital increased its Zimmer Biomet (ZBH) stake by 383% in Q1 2026, buying an estimated $1.22M and bringing the position to 16,774 shares worth $1.52M. The position accounts for 0.11% of the portfolio, ranked #184.

FORA Capital first reported a position in ZBH in Q4 2019 and has held it in 13 quarters since. The position peaked at $4.14M in Q3 2024. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

FORA Capital held 16,774 shares of Zimmer Biomet worth $1.52M as of Q1 2026.
FORA Capital bought 13,299 Zimmer Biomet shares in Q1 2026, an estimated $1.22M.
Zimmer Biomet made up 0.11% of FORA Capital's portfolio in Q1 2026, its #184 holding.
FORA Capital first reported a position in Zimmer Biomet in Q4 2019 and has held it in 13 quarters since.
FORA Capital's Zimmer Biomet position peaked at $4.14M in Q3 2024.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on FORA Capital's 13F filing for Q1 2026, filed 15 May 2026.